Session Details

[FP5]Free Paper 5_Consultation-Liaison Psychiatry

Thu. Jun 18, 2026 11:40 AM - 1:00 PM JST
Thu. Jun 18, 2026 2:40 AM - 4:00 AM UTC
ポスター会場(パシフィコ横浜ノース 1F G1~G4)FP2,FP5,FP5,FP11,FP14,FP17
Chairperson:Katsuji Nishimura(Hamano Hospital)

[1-FP5-1]精神疾患を持つ患者が身体疾患の治療を行うことに対する医療者側の理解 ―症例を通じた問題提起―

Junichi Saito1,2, Haruka Masuda1,3, Mayu Goto2,4, Akiko Kurosawa2,5, Nami Shimojo2,5, Kumiko Maeda2,5, Shoichi Miyata2,6, Yoichi Nakamura2,7, Takahiro Nemoto1,8 (1.Department of Neuropsychiatry, Toho University Faculty of Medicine, Tokyo, Japan, 2.Palliative Care Center, Toho University Omori Medical Center, Tokyo, Japan, 3.Department of Neuropsychiatry, Toho University Graduate School of Medicine, Tokyo, Japan, 4.Department of General and Gastroenterological Surgery, Toho University Omori Medical Center, Tokyo, Japan, 5.Department of Nursing, Toho University Omori Medical Center, Tokyo, Japan, 6.Department of Pharmacy, Toho University Omori Medical Center, Tokyo, Japan, 7.Division of Palliative Medicine, Department of Clinical Oncology, Toho University School of Medicine, Tokyo, Japan, 8.Departmentof Psychiatry and Implementation Science, Toho University Faculty of Medicine, Tokyo, Japan)

[1-FP5-2]精神科医不在の総合病院向けに開発したリエゾンコンサルテーションロボットを用いた診療の優位性

Takeshi Iwanaga1,2, Hidenobu Sumioka3, Miyuki Shigeyama4, Hirokazu Kumazaki1,2,5 (1.Department of Neuropsychiatry, Graduate School of Biomedical Nagasaki University, 2.Department of Neuropsychiatry, Nagasaki University Hospital, 3.Advanced Telecommunications Research Institute International, 4.Hokusyou Hospital, 5.Kanazawa University)

[1-FP5-3]鉄補充療法で改善を認めたがん患者のレストレスレッグス症候群の1例

Hitoshi Muto (Japanese Red Cross Musashino Hospital)

[1-FP5-4]せん妄リスクを考慮した入院患者における睡眠薬投与状況

Ken Wada1, Nozomi Minao1, Kenichi Oga2, Takahiro Sugita2, Misa Yoshida2, Yutaka Kuriyama3 (1.Department of Psychiatry, Hiroshima Citizens Hospital, Hiroshima City Hospital Organization, 2.Department of Psychiatry and Neurosciences, Hiroshima University Graduate School of Biomedical Science, 3.Jikei Hospital)

[1-FP5-5]ICUせん妄後の認知機能低下に関連するDNAメチル化プロファイルによる新規バイオマーカー探索

Yoshitaka Nishizawa1, Tetsufumi Kanazawa1, Gen Shinozaki2 (1.Osaka Medical and Pharmaceutical University School of Medicine, Department of Psychiatry, 2.Stanford University School of Medicine, Department of Psychiatry and Behavioral Sciences)

[1-FP5-6]ラメルテオンを使用した身体疾患患者におけるせん妄発生因子の後方視研究

Ryuji Henmi, Tomoyuki Nakamura, Motohiro Ozone (Department of Neuropsychiatry, Kurume University School of Medicine)

[1-FP5-7]Becker Muscular Dystrophy presented with Catatonic Schizophrenia - A Case Report

Nileswar Das, Aditya Somani, Lokesh Kumar. Singh, Jiten Kumar. Mishra, Amit Kumar. Chowhan, Saravana Sukriya, Laksh Bajaj, Sanjana Agrawal (All India Institute of Medical Sciences, Raipur, India)

[1-FP5-8]演題取り下げ

Ziara Carmelli G. Tan, Irene Carmelle S. Tan (University of the Philippines Philippine General Hospital Department of Psychiatry and Behavioral Medicine, Philippines)